168 related articles for article (PubMed ID: 2528367)
1. Inhibition of normal and psoriatic epidermal phospholipase A2 by picomolar concentrations of recombinant human lipocortin I.
Cartwright PH; Ilderton E; Sowden JM; Yardley HJ
Br J Dermatol; 1989 Aug; 121(2):155-60. PubMed ID: 2528367
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of phospholipase A2 by protein I.
Khanna NC; Hee-Chong M; Severson DL; Tokuda M; Chong SM; Waisman DM
Biochem Biophys Res Commun; 1986 Sep; 139(2):455-60. PubMed ID: 2945554
[TBL] [Abstract][Full Text] [Related]
3. Characterization of lipocortin I and an immunologically unrelated 33-kDa protein as epidermal growth factor receptor/kinase substrates and phospholipase A2 inhibitors.
Haigler HT; Schlaepfer DD; Burgess WH
J Biol Chem; 1987 May; 262(14):6921-30. PubMed ID: 3032981
[TBL] [Abstract][Full Text] [Related]
4. Phospholipase A2 and lipocortin effects.
Dennis EA; Davidson FF
Prog Clin Biol Res; 1990; 349():47-54. PubMed ID: 2144646
[No Abstract] [Full Text] [Related]
5. Monoclonal antibodies specific to a Ca2(+)-bound form of lipocortin I distinguish its Ca2(+)-dependent phospholipid-binding ability from its ability to inhibit phospholipase A2.
Hayashi H; Owada MK; Sonobe S; Domae K; Yamanouchi T; Kakunaga T; Kitajima Y; Yaoita H
Biochem J; 1990 Aug; 269(3):709-15. PubMed ID: 2143895
[TBL] [Abstract][Full Text] [Related]
6. Calcium-independent phospholipases from guinea pig digestive tract as probes to study the mechanism of lipocortin.
Gassama-Diagne A; Fauvel J; Chap H
J Biol Chem; 1990 Mar; 265(8):4309-14. PubMed ID: 2137821
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of phospholipase A2 by "lipocortins" and calpactins. An effect of binding to substrate phospholipids.
Davidson FF; Dennis EA; Powell M; Glenney JR
J Biol Chem; 1987 Feb; 262(4):1698-705. PubMed ID: 2948959
[TBL] [Abstract][Full Text] [Related]
8. Limitations of phosphatidylcholine/deoxycholate mixtures for the analysis of phospholipase A2 inhibition and activation: illustration with annexins.
Davidson FF; Dennis EA
Biochim Biophys Acta; 1992 Aug; 1127(3):270-6. PubMed ID: 1387325
[TBL] [Abstract][Full Text] [Related]
9. Modulation of phospholipase A2 activity in extracts of lesion-free psoriatic epidermis by alkaline phosphatase and a protein phosphatase inhibitor.
Cartwright PH; Ilchyshyn A; Ilderton E; Yardley HJ
Br J Dermatol; 1988 Mar; 118(3):333-8. PubMed ID: 2833303
[TBL] [Abstract][Full Text] [Related]
10. [Lipocortin--a Ca2+-binding protein which has anti-phospholipase A2 activity].
Tokuda M; Waisman DM; Hatase O
Seikagaku; 1988 Jan; 60(1):26-31. PubMed ID: 2969024
[No Abstract] [Full Text] [Related]
11. Lipocortin inhibition of extracellular and intracellular phospholipases A2 is substrate concentration dependent.
Aarsman AJ; Mynbeek G; van den Bosch H; Rothhut B; Prieur B; Comera C; Jordan L; Russo-Marie F
FEBS Lett; 1987 Jul; 219(1):176-80. PubMed ID: 2954856
[TBL] [Abstract][Full Text] [Related]
12. Lipocortin-independent effect of dexamethasone on phospholipase activity in a thymic epithelial cell line.
Piltch A; Sun L; Fava RA; Hayashi J
Biochem J; 1989 Jul; 261(2):395-400. PubMed ID: 2528346
[TBL] [Abstract][Full Text] [Related]
13. Lipocortin-like anti-phospholipase A2 activity of endonexin.
Fauvel J; Salles JP; Roques V; Chap H; Rochat H; Douste-Blazy L
FEBS Lett; 1987 May; 216(1):45-50. PubMed ID: 2953628
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of human skin phospholipase A2 by "lipocortins" is an indirect effect of substrate/lipocortin interaction.
Bastian BC; Sellert C; Seekamp A; Römisch J; Pâques EP; Bröcker EB
J Invest Dermatol; 1993 Sep; 101(3):359-63. PubMed ID: 8370974
[TBL] [Abstract][Full Text] [Related]
15. Purification and characterization of a 32-kDa phospholipase A2 inhibitory protein (lipocortin) from human peripheral blood mononuclear cells.
Rothhut B; Comera C; Prieur B; Errasfa M; Minassian G; Russo-Marie F
FEBS Lett; 1987 Jul; 219(1):169-75. PubMed ID: 2954855
[TBL] [Abstract][Full Text] [Related]
16. Glucocorticoid-induced modulation of the beta-adrenergic adenylate cyclase response of epidermis: its relation to epidermal phospholipase A2 activity.
Iizuka H; Kajita S; Mizumoto T; Kawaguchi H
J Invest Dermatol; 1986 Nov; 87(5):577-81. PubMed ID: 3021859
[TBL] [Abstract][Full Text] [Related]
17. Sedimentation equilibrium analysis of five lipocortin-related phospholipase A2 inhibitors from human placenta. Evidence against a mechanistically relevant association between enzyme and inhibitor.
Ahn NG; Teller DC; Bienkowski MJ; McMullen BA; Lipkin EW; de Haën C
J Biol Chem; 1988 Dec; 263(35):18657-63. PubMed ID: 2974032
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of phospholipase A2 inhibitory proteins in human mononuclear cells.
Coméra C; Rothhut B; Russo-Marie F
Eur J Biochem; 1990 Feb; 188(1):139-46. PubMed ID: 2138536
[TBL] [Abstract][Full Text] [Related]
19. Epidermal phospholipase A2 activity is raised in the uninvolved skin of psoriasis.
Forster S; Ilderton E; Summerly R; Yardley HJ
Br J Dermatol; 1983 Jul; 109 Suppl 25():30-5. PubMed ID: 6860582
[TBL] [Abstract][Full Text] [Related]
20. Binding and inhibition studies on lipocortins using phosphatidylcholine vesicles and phospholipase A2 from snake venom, pancreas, and a macrophage-like cell line.
Davidson FF; Lister MD; Dennis EA
J Biol Chem; 1990 Apr; 265(10):5602-9. PubMed ID: 2138608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
